136 related articles for article (PubMed ID: 2581667)
21. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice.
Maruyama T; Watanabe K; Yanagawa T; Kasatani T; Kasuga A; Shimada A; Takei I; Suzuki Y; Kataoka K; Saruta T
Diabetes Res; 1991 Apr; 16(4):171-5. PubMed ID: 1802483
[TBL] [Abstract][Full Text] [Related]
22. Differential reactivities of fucosyl GM1 and GM1 gangliosides on rat erythrocyte membrane revealed by analysis with anti-fucosyl GM1 and GM1 antisera.
Iwamori M; Shimomura J; Tsuyuhara S; Mogi M; Ishizaki S; Nagai Y
J Biochem; 1983 Jul; 94(1):1-10. PubMed ID: 6619101
[TBL] [Abstract][Full Text] [Related]
23. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
[TBL] [Abstract][Full Text] [Related]
24. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
25. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
Suzuki S; Suzuki R; Onta T; Kumagai K
Nat Immun Cell Growth Regul; 1986; 5(2):75-89. PubMed ID: 3487716
[TBL] [Abstract][Full Text] [Related]
26. Wide distribution of rat hepatoma asialo GM1 and its different responses to anti-asialo GM1 antibody-mediated in vitro and in situ cell killing.
Iwamori M; Sunada S; Ishihara E; Masago H; Manabe M; Taguchi H; Satoh H; Nagai Y
Jpn J Cancer Res; 1987 Jun; 78(6):621-7. PubMed ID: 3112077
[TBL] [Abstract][Full Text] [Related]
27. A monoclonal antibody with reactivity to asialo GM1 and murine natural killer cells.
Solomon FR; Higgins TJ
Mol Immunol; 1987 Jan; 24(1):57-65. PubMed ID: 3614206
[TBL] [Abstract][Full Text] [Related]
28. Anti asialo GM1 antibody detected in the patients' sera from systemic lupus erythematosus and Behçet's diseases with neurological manifestations.
Hirano T; Miyajima H; Taniguchi O; Ueda A; Takai S; Hashimoto H; Hirose S; Okumura K
Jpn J Med; 1988 May; 27(2):167-71. PubMed ID: 3418980
[TBL] [Abstract][Full Text] [Related]
29. Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1.
Marcus DM; Perry L; Gilbert S; Preud'homme JL; Kyle R
J Immunol; 1989 Nov; 143(9):2929-32. PubMed ID: 2572647
[TBL] [Abstract][Full Text] [Related]
30. An immunosuppressive factor interacts with membrane glycolipid asialo-GM1 structure.
Wang KC; Verret CR; Yu RK; Gershon RK; Lee S
Immunobiology; 1987 Mar; 174(2):139-45. PubMed ID: 3596633
[TBL] [Abstract][Full Text] [Related]
31. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
Hinuma S; Naruo K; Ootsu K; Houkan T; Shiho O; Tsukamoto K
Immunology; 1987 Feb; 60(2):173-9. PubMed ID: 3493209
[TBL] [Abstract][Full Text] [Related]
32. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
[TBL] [Abstract][Full Text] [Related]
33. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
Keller R; Bächi T; Okumura K
Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344
[TBL] [Abstract][Full Text] [Related]
34. A glycolipid on the surface of mouse natural killer cells.
Kasai M; Iwamori M; Nagai Y; Okumura K; Tada T
Eur J Immunol; 1980 Mar; 10(3):175-80. PubMed ID: 6966574
[TBL] [Abstract][Full Text] [Related]
35. Anti-asialo-GM1 inhibits vaccinia virus infection of murine ovaries: asialo-GM1 as an additional virus receptor?
Karupiah G; Blanden RV
Immunol Cell Biol; 1990 Oct; 68 ( Pt 5)():343-6. PubMed ID: 2083955
[TBL] [Abstract][Full Text] [Related]
36. Display of the neutral glycolipid ganglio-n-tetraosylceramide (asialo GM1) on cells of the natural killer and T lineages.
Beck BN; Gillis S; Henney CS
Transplantation; 1982 Feb; 33(2):118-22. PubMed ID: 6977214
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous transfer of gangliotetraosylceramide between phospholipid vesicles.
Brown RE; Sugár IP; Thompson TE
Biochemistry; 1985 Jul; 24(15):4082-91. PubMed ID: 4052384
[TBL] [Abstract][Full Text] [Related]
38. Factors regulating the expression of the neutral glycolipids in the mouse small intestinal mucosa.
Umesaki Y; Ohara M
Biochim Biophys Acta; 1989 Feb; 1001(2):163-8. PubMed ID: 2917140
[TBL] [Abstract][Full Text] [Related]
39. Organization of the glycosphingolipid asialo-GM1 in phosphatidylcholine bilayers.
Tillack TW; Wong M; Allietta M; Thompson TE
Biochim Biophys Acta; 1982 Oct; 691(2):261-73. PubMed ID: 7138860
[TBL] [Abstract][Full Text] [Related]
40. Treatment of mice with anti-asialo-GM1 antibody or poly-I:C: effects on metastasis dissociable from modulation of macrophage antitumor activity.
Riser BL; Laybourn KA; Varani J
Nat Immun Cell Growth Regul; 1988; 7(5-6):305-15. PubMed ID: 3221908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
